Neptune Biotech: Announcement on completing the registration of industrial and commercial changes
Haiwang Biotech: Announcement on not holding a shareholders\' meeting
Haiwang Biotech: Legal Opinions of Beijing Deheng (Shenzhen) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Shenzhen Haiwang Biotech Co., Ltd.
Haiwang Biotech: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Neptune Biotech: General Manager Job Rules (August 2024)
Neptune Biotech: Semi-annual non-operating capital usage and other related capital transactions summary table
Neptune Biotech: Announcement on reducing registered capital and amending the company\'s articles of association
Neptune Biotech: Foreign Investment Management System (August 2024)
Neptune Biotech: 2024 Semi-Annual Financial Report
Kaiwang Biotech: Board Secretary Work System (August 2024)
Haiwang Biotech: Announcement on the Notice of Convening the Third Extraordinary General Meeting of Shareholders in 2024
Shenzhen Neptunus Bioengineering: Announcement regarding the risk warnings and remedial measures for dilutive immediate returns of A shares issued to specific parties by the company in 2024 and promises made by related parties.
Shenzhen Neptunus Bioengineering: Announcement of Change in Controlling Shareholder and Actual Controller
Shenzhen Neptunus Bioengineering: Announcement on Progress of Planning Major Matters
Shenzhen Neptunus Bioengineering: Announcement of Resolutions of the Shareholders' Meeting for the Fiscal Year 2023
Shenzhen Neptunus Bioengineering: Legal Opinion of Beijing Deheng (Shenzhen) Law Firm Regarding the 2023 Annual Shareholders' Meeting of Shenzhen Neptunus Bioengineering Co., Ltd.
Shenzhen Neptunus Bioengineering: Progress announcements on planning important matters
Shenzhen Neptunus Bioengineering: Progress announcements on planning important matters
Shenzhen Neptunus Bioengineering: Announcement on the Notice of Convening the 2023 Annual General Meeting of Shareholders
Shenzhen Neptunus Bioengineering: Announcement on the 2023 write-off of bad debts and preparation for asset impairment